These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1030425)

  • 1. Long term storage studies with a new stabilised formulation of yellow fever virus vaccine.
    Finter NB; Burfoot C; Young PA; Ferris R
    Dev Biol Stand; 1976 Oct; 36():279-83. PubMed ID: 1030425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of yellow fever vaccine.
    Monath TP
    Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of live, freeze-dried virus vaccines.
    Peetermans J; Colinet G; Bouillet A; D'Hondt E; Stephenne J
    Dev Biol Stand; 1976 Oct; 36():291-6. PubMed ID: 1030427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adverse storage on live virus vaccines.
    Finter NB; Ferris R; Kelly A; Prydie J
    Dev Biol Stand; 1978; 41():271-6. PubMed ID: 753656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability characteristics of freeze-dried human live virus vaccines.
    Cowdery S; Frey M; Orlowski S; Gray A
    Dev Biol Stand; 1976 Oct; 36():297-303. PubMed ID: 1030428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of 17D yellow fever virus vaccine using different stabilizers.
    Adebayo AA; Sim-Brandenburg JW; Emmel H; Olaleye DO; Niedrig M
    Biologicals; 1998 Dec; 26(4):309-16. PubMed ID: 10403034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-related issues.
    Rev Infect Dis; 1982; 4(5):972-7. PubMed ID: 7146734
    [No Abstract]   [Full Text] [Related]  

  • 8. [The quality standardization of a national vaccine against yellow fever].
    Rasshchepkina MN; Levina VD; Vorob'eva MS; Kozlov VG
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):47-50. PubMed ID: 2251891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow fever vaccine.
    Arya SC
    Emerg Infect Dis; 1999; 5(3):487-9. PubMed ID: 10341198
    [No Abstract]   [Full Text] [Related]  

  • 10. The development of an improved experimental yellow fever vaccine.
    Tannock GA; Wark MC; Hair CG
    J Biol Stand; 1980; 8(1):23-34. PubMed ID: 7400156
    [No Abstract]   [Full Text] [Related]  

  • 11. A varicella vaccine stable at 5 degrees C.
    Fanget B; Françon A
    Dev Biol Stand; 1996; 87():167-71. PubMed ID: 8854014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of freeze-dried and reconstituted measles vaccines.
    Peetermans J; Colinet G; Stephenne J; Bouillet A
    Dev Biol Stand; 1978; 41():259-64. PubMed ID: 753654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thermal stability of a stabilized 17D yellow fever virus vaccine.
    Burfoot C; Young PA; Finter NB
    J Biol Stand; 1977; 5(3):173-9. PubMed ID: 893463
    [No Abstract]   [Full Text] [Related]  

  • 15. Stability-related studies on 17D yellow fever vaccine.
    Perraut R; Girault G; Moreau JP
    Microbes Infect; 2000 Jan; 2(1):33-8. PubMed ID: 10717538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous administration of hepatitis B and yellow fever vaccines.
    Yvonnet B; Coursaget P; Deubel V; Diop-Mar I; Digoutte JP; Chiron JP
    Dev Biol Stand; 1986; 65():205-7. PubMed ID: 2951287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new combined vaccine against yellow fever and measles in infants aged 6 to 24 months in Mali].
    Soula G; Sylla A; Pichard E; Kodio B; Bentejac MC; Teulières L; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):885-97. PubMed ID: 1819436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines.
    Artenstein MS
    Bull World Health Organ; 1971; 45(3):287-90. PubMed ID: 5316909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization. Is it real or assumed? Results of a retrospective study].
    Poveda JD; Raccurt CP; Le Fur R; M'Bailara L; Malvy JM; Le Bras M; Saliou P; Fleury HJ
    Bull Soc Pathol Exot; 1990; 83(4):529-35; discussion 535-6. PubMed ID: 2286006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thermostabilization of the lyophilized yellow fever vaccine 17-D. II. Pilot lots prepared under conditions of industrial production].
    Barme M; Vacher B; Ryhiner ML; Chabannier G
    J Biol Stand; 1987 Jan; 15(1):67-72. PubMed ID: 3558422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.